Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|Thymoquinone||TQ|Thymoquinon||Thymoquinone is a compound derived from the Nigella sativa plant that targets multiple kinases has anti-tumor activity (PMID: 26023736, PMID: 25847385, PMID: 32721537).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||breast cancer||not applicable||Thymoquinone||Preclinical - Cell line xenograft||Actionable||In a preclinical study, Thymoquinone (TQ) inhibited growth, migration, and invasive behavior of human breast cancer cell lines in culture, and inhibited tumor growth and metastasis in mouse breast cancer cell line xenografts (PMID: 26023736).||26023736|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|